Clinical Trials on Recurrent Thymoma and Thymic Carcinoma in Netherlands

Total 1012 results

Erasmus Medical Center
Hospices Civils de Lyon; Maastro Clinic, The Netherlands

Recruiting

Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors (INTHYM)

Thymic Carcinoma | Thymoma | Thymic Epithelial Tumor | Thymoma and Thymic Carcinoma

Netherlands
European Organisation for Research and Treatment...
ETOP IBCSG Partners Foundation

Active, not recruiting

Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) (NIVOTHYM)

Thymic Carcinoma | Thymoma Type B3

Netherlands, Spain, France, Belgium, United Kingdom, Switzerland
Radboud University Medical Center
Dutch Cancer Society

Recruiting

Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma Patients (INTRO)

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

Netherlands
UMC Utrecht
Dutch Pancreatic Cancer Group (DPCG)

Enrolling by invitation

Recurrent Disease Detection After Resection of Pancreatic Adenocarcinoma Using a Standardized Surveillance Strategy (RADAR-PANC)

Resectable Pancreatic Ductal Adenocarcinoma | Recurrent Pancreatic Ductal Adenocarcinoma

Netherlands
UMC Utrecht

Completed

Maternal Embryo Interaction in Recurrent Miscarriages (MEER)

Recurrent Miscarriages

Netherlands
Amphia Hospital
Albert Schweitzer Hospital

Recruiting

Folinic Acid for Prevention of Pemetrexed-induced Toxicity (FLEX)

NSCLC | Thymoma | Mesothelioma

Netherlands
Leiden University Medical Center
University Medical Center Groningen

Completed

Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian Cancer (PITCH)

Recurrent Ovarian Cancer

Netherlands
Leiden University Medical Center

Recruiting

Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer (OVACURE)

Ovarian Cancer Recurrent

Netherlands
Radboud University Medical Center
Triodos Foundation

Completed

Mindfulness Based Compassionate Living in Recurrent Depression (MBCL-RD)

Recurrent Depression

Netherlands
PCI Biotech AS

Terminated

A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.

Recurrent Head and Neck Cancer | Carcinoma, Squamous Cell of Head and Neck

Germany, United Kingdom, France, Lithuania, Netherlands, Poland
Radboud University Medical Center
IBSA Institut Biochimique SA; Goodlife Pharma B.V.

Recruiting

Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study (GT RACING)

Recurrent Urinary Tract Infection

Netherlands
Leiden University Medical Center
Radboud University Medical Center; Maastricht University Medical Center; Erasmus... and other collaborators

Recruiting

Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages (PREMI)

Miscarriage | Recurrent Miscarriage | Fertility Disorders | Recurrent Pregnancy Loss | Habitual Abortion

Netherlands
Radboud University Medical Center

Unknown

A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer

Ovarian Cancer | Endometrial Cancer | Advanced/Recurrent Breast Cancer

Netherlands
Maastricht University Medical Center
Zuyderland Medical Centre

Recruiting

The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms

Candidiasis, Vulvovaginal | Recurrent Candidiasis of Vagina

Netherlands
Maastricht University Medical Center

Recruiting

Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs

Recurrence | Complication of Surgical Procedure | Skin Cancer | Recurrent Disease | Complication | Complication,Postoperative | Lentigo Maligna Melanoma | Basal Cell Carcinoma | Cutaneous Squamous Cell Carcinoma | Lentigo Maligna

Netherlands
Radboud University Medical Center
Maastricht University Medical Center

Recruiting

Aerobe Cycling Training in Women With Unexplained Recurrent Pregnancy Loss (HMOVE)

Recurrent Pregnancy Loss

Netherlands
Radboud University Medical Center
Maastricht University Medical Center; Erasmus Medical Center; Catharina Ziekenhuis... and other collaborators

Recruiting

PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer (PROMOTE)

Endometrial Cancer Recurrent | Endometrial Cancer Stage III | Endometrial Cancer Stage IV

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Confocal Laser Endomicroscopy in Pleural Malignancies

Pleural Diseases | Thymoma | Pleural Malignant Mesothelioma

Netherlands
Novartis Pharmaceuticals

Terminated

A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell Carcinoma

France, Taiwan, United States, Australia, Canada, Hong Kong, Singapore, Korea, Republic of, Netherlands
Leiden University Medical Center
Erasmus Medical Center; Catharina Ziekenhuis Eindhoven; Amsterdam UMC, location... and other collaborators

Recruiting

SGM-101 in Locally Advanced and Recurrent Rectal Cancer (SGM-LARRC)

Rectal Cancer | Recurrent Rectal Cancer

Netherlands
Maastricht University Medical Center

Active, not recruiting

Interobserver Variability Desmoplasia

Recurrence | Metastasis | Pathology | Cutaneous Squamous Cell Carcinoma

Netherlands
Amsterdam UMC, location VUmc

Recruiting

A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme (STELLAR)

Glioblastoma | Glioblastoma Multiforme | GBM | Glioblastoma, Adult | Recurrent Brain Tumor

Netherlands
Acutus Medical

Completed

AcQMap Objectively Visualize the Etiology of Recurrent AF Following a Failed AF Ablation (RECOVER AF)

Recurrent Atrial Fibrillation

United Kingdom, Netherlands, Germany, Canada, Czechia, Belgium
University of Oslo
Göteborg University; UMC Utrecht; Medical University of Lodz; Amsterdam UMC, location...

Enrolling by invitation

The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing in Elderly Women With Recurrent UTI (ImpresUWP3)

Recurrent Urinary Tract Infection

Netherlands, Norway, Poland, Sweden
Radboud University Medical Center
ABX advanced biochemical compounds GmbH; Radboud Translational Medicine

Recruiting

F18-PSMA-1007 PET for Early Biochemical Recurrence of Prostate Cancer (PROPER-ABX)

Prostate Cancer Recurrent

Netherlands
UMC Utrecht
Dutch Pancreatic Cancer Group (DPCG)

Enrolling by invitation

Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapy (ARCADE)

Recurrent Pancreatic Ductal Adenocarcinoma

Netherlands
Ottawa Hospital Research Institute

Completed

Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS) (PREDICTORS)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Thromboembolic Disease Recurrent | Recurrent Thromboembolic Disease

Canada, Netherlands, Switzerland
Maastricht University Medical Center

Active, not recruiting

Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma

Recurrence | Carcinoma, Squamous Cell | Skin Cancer | Metastasis | Carcinoma, Squamous Cell of Head and Neck | Carcinoma, Squamous Cell, Skin

Netherlands
Princess Maxima Center for Pediatric Oncology
Innovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids Cancer

Not yet recruiting

HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies (HEM-iSMART C)

Acute Lymphoblastic Leukemia, in Relapse | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory

Netherlands
Princess Maxima Center for Pediatric Oncology
Innovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids Cancer

Not yet recruiting

HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological Malignancies (HEM-iSMART A)

Acute Lymphoblastic Leukemia, in Relapse | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory

Netherlands
Princess Maxima Center for Pediatric Oncology
Innovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids Cancer

Not yet recruiting

HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies (HEM-iSMART D)

Acute Lymphoblastic Leukemia, in Relapse | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin

Neuroendocrine Carcinomas

Netherlands
Princess Maxima Center for Pediatric Oncology
Innovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids Cancer

Not yet recruiting

HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies (HEM-iSMART B)

Acute Lymphoblastic Leukemia | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic...

Netherlands
Leiden University Medical Center
University Medical Center Groningen

Completed

Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer (CHIP)

Recurrent Ovarian Cancer

Netherlands
Catharina Ziekenhuis Eindhoven

Recruiting

Induction Chemotherapy for Locally Recurrent Rectal Cancer (PelvEx II)

Recurrent Rectal Cancer

Netherlands, Sweden, Belgium, Norway, Portugal
Novartis Pharmaceuticals

Completed

A Phase 2 Study of BGJ398 in Patients With Recurrent GBM

Recurrent Glioblastoma or Other Glioma Subtypes

Spain, Belgium, United States, Switzerland, Australia, Netherlands
Maastricht University Medical Center

Active, not recruiting

T1 Squamous Cell Carcinomas of the Lip

Recurrence | Surgery | Metastasis | Squamous Cell Carcinoma | Lip | Surgical Margin | Lip Cancer | Lip SCC | Squamous Cell Carcinoma of the Lip | Tumor Free Margins

Netherlands
Maastricht University Medical Center

Recruiting

Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region

Quality of Life | Satisfaction, Patient | Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma of Head and Neck | Skin Cancer | Squamous Cell Carcinomas | Squamous Cell Carcinoma of the Skin | Cutaneous Squamous Cell Carcinoma of the Head and Neck | Cutaneous Squamous Cell Carcinoma | High-Risk Cancer

Netherlands
Regeneron Pharmaceuticals

Recruiting

Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

Recurrent Endometrial Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer | Recurrent Primary Peritoneal Cancer

United States, Spain, Korea, Republic of, Italy, United Kingdom, Netherlands, Belgium, Australia, France, Israel
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)

Stage IV or Recurrent Non-Small Cell Lung Cancer

United States, Finland, Argentina, France, Italy, Brazil, Greece, Japan, Mexico, Romania, Spain, Sweden, United Kingdom, Australia, Austria, Belgium, Canada, Czechia, Germany, Hungary, Korea, Republic of, Netherlands, Poland, Switzerland and more
Novartis Pharmaceuticals

Completed

A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors

Advanced Solid Tumors | Recurrent or Refractory Medulloblastoma | Locally Advanced or Metastatic Basal Cell Carcinoma

United States, United Kingdom, Switzerland, Netherlands
Bayer

Completed

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

Advanced Recurrent Malignant Pleural Epithelioid Mesothelioma | Advanced Recurrent Malignant Peritoneal Epithelioid Mesothelioma | Advanced Recurrent Serous Ovarian Cancer | Advanced Pancreatic Ductal Adenocarcinoma (Optional, Dose Expansion, Not Initiated)

United States, Sweden, Netherlands, United Kingdom, Finland
Bristol-Myers Squibb

Active, not recruiting

A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung Cancer

Australia, Russian Federation, United States, Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Italy, Mexico, Poland, Romania, Spain, Switzerland, United Kingdom, Ireland, Netherlands
Maastricht University Medical Center

Active, not recruiting

cOCT Versus LC-OCT for Diagnosing Basal Cell Carcinoma: a Diagnostic Cohort Study

Basal Cell Carcinoma

Netherlands
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

Phase II Dutasteride in Combination With CAB vs CAB in SDC (DUCT)

Salivary Duct Carcinoma

Netherlands
dr. M.P. van den Tol MD PhD

Completed

PET-MRI After Radiofrequency Ablation (RFA) or Microwave Ablation (MWA)

Liver Neoplasms | Local Neoplasm Recurrence

Netherlands
The Netherlands Cancer Institute
AstraZeneca

Active, not recruiting

Improve Checkpoint-blockade Response in Advanced Urothelial Cancer (ICRA)

Urothelial Carcinoma

Netherlands
Radboud University Medical Center
Catharina Ziekenhuis Eindhoven; Maasstad Hospital; Evangelisches Krankenhaus... and other collaborators

Recruiting

Recurrences After Standard EMR vs Plus Thermal Ablation EMR (RESPECT)

Polyps of Colon | Recurrence, Local Neoplasm

Netherlands
University Medical Center Groningen
UMC Utrecht; Erasmus Medical Center

Recruiting

Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate (ICON)

Head and Neck Squamous Cell Carcinoma | Margin Assessment

Netherlands
Roswell Park Cancer Institute
Pfizer

Completed

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Clear Cell Sarcoma of the Kidney

United States, Netherlands

Clinical Trials on Recurrent Thymoma and Thymic Carcinoma in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations